These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 16170890

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Factor VIII: maximal benefit?
    Nour-Eldin F.
    Eur J Med; 1992 Apr; 1(1):55-7. PubMed ID: 1341979
    [No Abstract] [Full Text] [Related]

  • 4. Management of joint bleeding in hemophilia.
    Simpson ML, Valentino LA.
    Expert Rev Hematol; 2012 Aug; 5(4):459-68. PubMed ID: 22992238
    [Abstract] [Full Text] [Related]

  • 5. Progressing towards optimal management of haemophilia A patients with inhibitors. Foreword.
    Tarantino MD.
    Haemophilia; 2013 Jan; 19 Suppl 1():1. PubMed ID: 23278992
    [No Abstract] [Full Text] [Related]

  • 6. [Immune tolerance therapy for inhibitors in haemophilia A].
    Oldenburg J.
    Hamostaseologie; 2008 Oct; 28 Suppl 1():S23-5. PubMed ID: 18958334
    [Abstract] [Full Text] [Related]

  • 7. Temporarily successful eradication therapy in acquired haemophilia with high inhibitor titer: a case report with a new protocol.
    Ilonczai P, Schlammadinger A, Oláh Z, Rázsó K, Bereczky Z, Boda Z.
    Thromb Haemost; 2008 Jul; 100(1):149-50. PubMed ID: 18612550
    [No Abstract] [Full Text] [Related]

  • 8. Inhibitor development in two cousins receiving full-length factor VIII (FVIII) and FVIII-Fc fusion protein.
    Ragni MV, Alabek M, Malec LM.
    Haemophilia; 2016 Sep; 22(5):e462-4. PubMed ID: 27501368
    [No Abstract] [Full Text] [Related]

  • 9. Porcine factor VIII.
    Giangrande PL.
    Haemophilia; 2012 May; 18(3):305-9. PubMed ID: 22531020
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy and safety evaluation of sucrose-formulated recombinant factor VIII for Taiwanese patients with haemophilia A.
    Young JH, Liu HC, Hsueh EJ, Huang ML, Peng CT, Chen RL, Maas-Enriquez M, Achilles K.
    Haemophilia; 2009 Jul; 15(4):968-70. PubMed ID: 19473407
    [No Abstract] [Full Text] [Related]

  • 11. Postpartum acquired factor VIII inhibitors.
    Franchini M.
    Am J Hematol; 2006 Oct; 81(10):768-73. PubMed ID: 16868941
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Immune tolerance: critical issues of factor dose, purity and treatment complications.
    DiMichele DM.
    Haemophilia; 2006 Dec; 12 Suppl 6():81-5; discussion 85-6. PubMed ID: 17123399
    [Abstract] [Full Text] [Related]

  • 15. Haemophilia A and inhibitors: advances in prevention and ITI treatment optimization.
    Kruse-Jarres R.
    Haemophilia; 2014 Sep; 20 Suppl 6():1. PubMed ID: 24975699
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Including the life-time cumulative number of joint bleeds in the definition of primary prophylaxis.
    den Uijl IE, Fischer K.
    Thromb Haemost; 2008 May; 99(5):965; author reply 966-8. PubMed ID: 18449430
    [No Abstract] [Full Text] [Related]

  • 18. Induction of tolerance using porcine factor VIII.
    Hay CR, Laurian Y.
    Vox Sang; 1996 May; 70 Suppl 1():68-9. PubMed ID: 8869473
    [No Abstract] [Full Text] [Related]

  • 19. Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors.
    Reipert BM, van Helden PM, Schwarz HP, Hausl C.
    Br J Haematol; 2007 Jan; 136(1):12-25. PubMed ID: 17222196
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.